Hallal David — SEC insider filings

SEC reporting owner CIK 1457477. 40 insider filings on record with FilingPulse; latest filed 2026-09-23.

Transaction summary — filings shown

Covers all 40 filings on record, filed 2020-10-21 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kalaris Therapeutics, Inc. (KLRS)Director15—8 legs · 1,157,004 sh · $8,928,1059
Scholar Rock Holding Corp (SRRK)Chief Executive Officer, Director12—2 legs · 88,065 sh · $3,970,83812
iTeos Therapeutics, Inc. (ITOS)Director8—8 legs · 194,297 sh · $3,940,11825
Seer, Inc. (SEER)Director5——7

Insider filings — Hallal David

FiledFormIssuerReported transactionsSource
2026-09-234Scholar Rock Holding Corp (SRRK)Gift (G): 36,652 @ $0EDGAR
2026-06-044Kalaris Therapeutics, Inc. (KLRS)Grant/award (A): 9,000 (derivative) @ $0EDGAR
2026-04-204Scholar Rock Holding Corp (SRRK)Sale (S): 30,615 @ $49.57EDGAR
2026-02-114Scholar Rock Holding Corp (SRRK)Grant/award (A): 128,004 @ $0EDGAR
2026-01-154Scholar Rock Holding Corp (SRRK)Sale (S): 57,450 @ $42.70EDGAR
2025-10-094Scholar Rock Holding Corp (SRRK)Gift (G): 205,000 @ $0EDGAR
2025-08-294iTeos Therapeutics, Inc. (ITOS)Disposition to issuer (D): 25,140 (derivative) · Disposition to issuer (D): 146,160 (derivative)EDGAR
2025-06-064iTeos Therapeutics, Inc. (ITOS)Option exercise (M): 38,227 @ $4.30 · Sale (S): 38,227 @ $10.07 · Option exercise (M): 38,227 @ $4.30 · Sale (S): 38,227 @ $10.15 · Option exercise (M): 38,228 @ $4.30 · Sale (S): 38,228 @ $10.24 · +3 moreEDGAR
2025-05-064Scholar Rock Holding Corp (SRRK)Grant/award (A): 275,167 (derivative) @ $0EDGAR
2025-04-294Scholar Rock Holding Corp (SRRK)Grant/award (A): 250,000 @ $0 · Grant/award (A): 1,250,000 @ $0EDGAR
2025-04-114Kalaris Therapeutics, Inc. (KLRS)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2024-07-014Scholar Rock Holding Corp (SRRK)Grant/award (A): 13,500 @ $0 · Grant/award (A): 18,000 (derivative) @ $0EDGAR
2024-06-144Seer, Inc. (SEER)Grant/award (A): 58,178 @ $0EDGAR
2024-06-134iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 24,200 (derivative) @ $0EDGAR
2024-06-074Allovir, Inc. (ALVR)Grant/award (A): 35,000 @ $0EDGAR
2023-06-224Scholar Rock Holding Corp (SRRK)Grant/award (A): 36,000 (derivative) @ $0EDGAR
2023-06-164Seer, Inc. (SEER)Grant/award (A): 23,443 @ $0 · Grant/award (A): 34,735 (derivative) @ $0EDGAR
2023-06-154iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 22,383 (derivative) @ $0EDGAR
2023-05-124Allovir, Inc. (ALVR)Grant/award (A): 35,000 @ $0EDGAR
2022-10-214Allovir, Inc. (ALVR)Sale (S): 600,000 @ $8.45EDGAR
2022-09-304Allovir, Inc. (ALVR)Sale (S): 400,000 @ $7.35EDGAR
2022-08-014Allovir, Inc. (ALVR)Grant/award (A): 3,253,796 @ $4.61EDGAR
2022-07-214Allovir, Inc. (ALVR)Sale (S): 4,227 @ $5.33EDGAR
2022-06-214Scholar Rock Holding Corp (SRRK)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2022-06-174Seer, Inc. (SEER)Grant/award (A): 9,945 @ $0 · Grant/award (A): 29,640 (derivative) @ $0EDGAR
2022-06-104iTeos Therapeutics, Inc. (ITOS)Option exercise (M): 5,968 @ $4.23 · Sale (S): 5,968 @ $20.39 · Option exercise (M): 11,899 @ $2.95 · Sale (S): 11,899 @ $20.39 · Option exercise (M): 10,577 @ $4.23 · Sale (S): 10,577 @ $19.86 · +7 moreEDGAR
2022-06-064Allovir, Inc. (ALVR)Sale (S): 65,725 @ $3.67EDGAR
2022-05-274Scholar Rock Holding Corp (SRRK)Grant/award (A): 28,000 (derivative) @ $0EDGAR
2022-05-194Allovir, Inc. (ALVR)Grant/award (A): 27,500 (derivative) @ $0EDGAR
2022-04-224Allovir, Inc. (ALVR)Sale (S): 4,227 @ $5.87EDGAR
2022-03-114Allovir, Inc. (ALVR)Sale (S): 40,481 @ $7.55 · Sale (S): 25,244 @ $7.37EDGAR
2022-01-254Allovir, Inc. (ALVR)Sale (S): 17,100 @ $8.01EDGAR
2021-12-224iTeos Therapeutics, Inc. (ITOS)Option exercise (M): 20,000 @ $4.30 · Option exercise (M): 30,000 @ $2.95 · Sale (S): 50,000 @ $43.57 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2021-06-224Seer, Inc. (SEER)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-214iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 16,608 (derivative) @ $0EDGAR
2021-06-014Scholar Rock Holding Corp (SRRK)Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-05-274Allovir, Inc. (ALVR)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2021-01-254Allovir, Inc. (ALVR)Grant/award (A): 147,000 @ $0 · Grant/award (A): 273,000 (derivative) @ $0EDGAR
2020-12-114Seer, Inc. (SEER)Grant/award (A): 18,691 (derivative) @ $0EDGAR
2020-10-214/AiTeos Therapeutics, Inc. (ITOS)Grant/award (A): 16,608 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1457477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs